DroNABinol 5 mg Oral Capsule
RxNorm 197636
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 197636 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: droNABinol 5 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Dronabinol 5 mg Oral Capsule
(Atom ID: 11348826)
PSNPrescribable
Prescribable Name (PSN):
DroNABinol 5 mg Oral Capsule
(Atom ID: 6362712)
SYPrescribable
Synonym (SY):
Dronabinol 5 mg Oral Capsule
(Atom ID: 2966389)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
DroNABinol 5 mg Oral Capsule
(Atom ID: 12814036)
PTPrescribable
Designated preferred name (PT):
Dronabinol 5 mg oral capsule
(Atom ID: 10297685)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely dronabinol 5 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10311851)
Patient Education
Dronabinol
Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat loss of appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). Dronabinol is in a class of medications called cannabinoids. It works by affecting the area of the brain that controls nausea, vomiting, and appetite.
[Learn More]
* Please review the disclaimer below.